JP2012503024A5 - - Google Patents

Download PDF

Info

Publication number
JP2012503024A5
JP2012503024A5 JP2011528081A JP2011528081A JP2012503024A5 JP 2012503024 A5 JP2012503024 A5 JP 2012503024A5 JP 2011528081 A JP2011528081 A JP 2011528081A JP 2011528081 A JP2011528081 A JP 2011528081A JP 2012503024 A5 JP2012503024 A5 JP 2012503024A5
Authority
JP
Japan
Prior art keywords
peptidomimetic macrocycle
amino acid
peptidomimetic
independently
macrocycle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011528081A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012503024A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/057927 external-priority patent/WO2010034028A1/en
Publication of JP2012503024A publication Critical patent/JP2012503024A/ja
Publication of JP2012503024A5 publication Critical patent/JP2012503024A5/ja
Withdrawn legal-status Critical Current

Links

JP2011528081A 2008-09-22 2009-09-22 ペプチド模倣大環状分子 Withdrawn JP2012503024A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9917208P 2008-09-22 2008-09-22
US61/099,172 2008-09-22
PCT/US2009/057927 WO2010034028A1 (en) 2008-09-22 2009-09-22 Peptidomimetic marcrocycles

Publications (2)

Publication Number Publication Date
JP2012503024A JP2012503024A (ja) 2012-02-02
JP2012503024A5 true JP2012503024A5 (enExample) 2012-05-24

Family

ID=41581947

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011528081A Withdrawn JP2012503024A (ja) 2008-09-22 2009-09-22 ペプチド模倣大環状分子

Country Status (8)

Country Link
US (1) US20120115783A1 (enExample)
EP (1) EP2342214A1 (enExample)
JP (1) JP2012503024A (enExample)
CN (1) CN102197046A (enExample)
AU (1) AU2009294871A1 (enExample)
BR (1) BRPI0918833A2 (enExample)
CA (1) CA2737916A1 (enExample)
WO (1) WO2010034028A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0720306A2 (pt) 2006-12-14 2014-02-04 Aileron Therapeutics Inc Sistemas de macrociclização da bis-sufidrila
CA2678941C (en) 2007-02-23 2018-11-27 Aileron Therapeutics, Inc. Triazole macrocycle systems
JP5631201B2 (ja) 2007-03-28 2014-11-26 プレジデント アンド フェローズ オブ ハーバード カレッジ ステッチングされたポリペプチド
WO2010033879A2 (en) * 2008-09-18 2010-03-25 New York University Inhibiting interaction between hif-1a and p300/cbp with hydrogen bond surrogate-based helices
CN102482336B (zh) 2008-09-22 2015-05-06 爱勒让治疗公司 拟肽大环化合物
CA2743177A1 (en) 2008-11-24 2010-05-27 Aileron Therapeutics, Inc. Peptidomimetic macrocycles with improved properties
AU2010204648B2 (en) 2009-01-14 2016-09-01 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
JP2013505300A (ja) 2009-09-22 2013-02-14 エルロン・セラピューティクス・インコーポレイテッド ペプチド模倣大環状分子
KR102104762B1 (ko) 2010-08-13 2020-04-24 에일러론 테라퓨틱스 인코포레이티드 펩티도미메틱 거대고리
EP2627662B1 (en) 2010-10-13 2015-09-16 Bristol-Myers Squibb Company Methods for preparing macrocycles and macrocycle stabilized peptides
EP2768518A4 (en) 2011-10-18 2015-05-27 Aileron Therapeutics Inc PEPTIDOMIMETIC MACROCYCLES
CA2864120A1 (en) 2012-02-15 2013-08-22 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
RU2642299C2 (ru) 2012-02-15 2018-01-24 Эйлерон Терапьютикс, Инк. P53 пептидомиметические макроциклы
BR112015009470A2 (pt) 2012-11-01 2019-12-17 Aileron Therapeutics Inc aminoácidos dissubstituídos e seus métodos de preparação e uso
US9605026B2 (en) 2013-01-19 2017-03-28 New York University Hydrogen-bond surrogate peptides and peptidomimetics for p53 reactivation
WO2014138429A2 (en) * 2013-03-06 2014-09-12 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and use thereof in regulating hif1alpha
CN107106642B (zh) 2014-09-24 2021-02-26 艾瑞朗医疗公司 拟肽大环化合物及其制剂
EP3197478A4 (en) 2014-09-24 2018-05-30 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
JP2018516844A (ja) 2015-03-20 2018-06-28 エルロン・セラピューティクス・インコーポレイテッドAileron Therapeutics,Inc. ペプチド模倣大環状分子およびその使用
US10059741B2 (en) 2015-07-01 2018-08-28 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
EP3347372A4 (en) 2015-09-10 2019-09-04 Aileron Therapeutics, Inc. PEPTIDOMIMETIC MACROCYCLES AS MODULATORS OF MCL-1
EP4023295A1 (en) * 2020-12-29 2022-07-06 IDP Discovery Pharma, S.L. Vegf-regulating peptides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005044839A2 (en) * 2003-11-05 2005-05-19 Dana-Farber Cancer Institute, Inc. Stabilized alpha helical peptides and uses thereof
US8143228B2 (en) * 2004-07-12 2012-03-27 Medical Research Fund Of Tel Aviv Sourasky Medical Center Agents capable of downregulating an MSF-A dependent HIF-1α and use thereof in cancer treatment
US8940864B2 (en) * 2006-10-05 2015-01-27 New York Blood Center, Inc. Stabilized therapeutic small helical antiviral peptides
BRPI0720306A2 (pt) * 2006-12-14 2014-02-04 Aileron Therapeutics Inc Sistemas de macrociclização da bis-sufidrila
CA2678941C (en) * 2007-02-23 2018-11-27 Aileron Therapeutics, Inc. Triazole macrocycle systems

Similar Documents

Publication Publication Date Title
JP2013505300A5 (enExample)
JP2012510430A5 (enExample)
JP2012515172A5 (enExample)
JP2013535514A5 (enExample)
JP2015110654A5 (enExample)
JP2012515778A5 (enExample)
JP2022095872A5 (enExample)
RU2014137107A (ru) Пептидомиметические макроциклы
JP2010505741A5 (enExample)
CN101835801B (zh) 转铁蛋白变体和偶联物
JP2014530868A5 (enExample)
JP2019521139A5 (enExample)
JP6297969B2 (ja) 部位特異的モノpeg化エキセンジン類似体およびその調製方法
JP2015522576A5 (enExample)
JP2021100937A5 (enExample)
JP2015508777A5 (enExample)
JP7674031B2 (ja) 細胞透過性ペプチド
JP2011511076A5 (enExample)
TW201209062A (en) Amide based glucagon superfamily peptide prodrugs
CN102197046A (zh) 拟肽大环化合物
JP2018515101A5 (enExample)
DE602005021858D1 (de) Peptide der amylin familie, verfahren zu deren herstellung und verwendung
JP2013520986A5 (enExample)
CN1133047A (zh) 治疗用肽衍生物
JP2016511751A5 (enExample)